Raia Drogasil S.A.
RADL3
Kedudukan dalam Saham
#2647
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal... Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Harga Saham
$4.10
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$7.18B
Perubahan (1 hari)
4.09%
Perubahan (1 tahun)
13.29%
Negara
BR
Perdagangan Raia Drogasil S.A. (RADL3)
Kategori
Consumer Defensive
Pendapatan untuk Raia Drogasil S.A. (RADL3)
Pendapatan pada Jun 2026 TTM: $288.64M
Menurut laporan kewangan terkini Raia Drogasil S.A., pendapatan semasa syarikat ialah $288.64M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $250.74M, peningkatan berbanding pendapatan pada tahun 2022 yang berjumlah $225.70M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Raia Drogasil S.A. dari 2003 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $288.64M | 25.99% |
| 2024 | $229.10M | -8.63% |
| 2023 | $250.74M | 11.09% |
| 2022 | $225.70M | 27.37% |
| 2021 | $177.20M | 49.32% |
| 2020 | $118.68M | -39.16% |
| 2019 | $195.07M | 18.52% |
| 2018 | $164.59M | -20.60% |
| 2017 | $207.30M | 13.31% |
| 2016 | $182.95M | 65.89% |
| 2015 | $110.28M | -2.84% |
| 2014 | $113.50M | 92.24% |
| 2013 | $59.04M | -23.49% |
| 2012 | $77.16M | 57.81% |
| 2011 | $48.90M | -32.82% |
| 2010 | $72.78M | 20.53% |
| 2009 | $60.39M | 100.99% |
| 2008 | $30.05M | 71.58% |
| 2007 | $17.51M | 33.62% |
| 2006 | $13.10M | 131.37% |
| 2005 | $5.66M | 42.39% |
| 2004 | $3.98M | 20.41% |
| 2003 | $3.30M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $20.38B | 6,959.56% |
US
|
|
| $9.83B | 3,304.31% |
FR
|
|
| $2.94B | 918.90% |
US
|
|
| $1.55B | 436.99% |
IN
|
|
| $517.00M | 79.11% |
US
|
